An observational study in Anesthesia and Post Operative Pain, sponsored by Azienda Ospedaliero, Universitaria Pisana. Completed at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-05-24.
Sponsored by Azienda Ospedaliero, Universitaria Pisana · Observational
This study is to investigate whether a different volume of ropivacaine, with the same prescribed dosage based on body weight, can affect block efficacy, duration and side effects in the first 24 hours postoperatively.
patients were divided into 3 groups on the basis of the volume of anesthetic given to perform the block. in every patient was assessed the nrs, the side effects, if any, and the need for analgesic drugs in the first 24 hour after surgery
5,093 studies on the registry are indexed under Pain, Postoperative; 1,140 are open to participants now.
This study's enrollment of 120 is above the median of 102 across 608 observational studies indexed under Pain, Postoperative.
Browse Pain, Postoperative studies →Azienda Ospedaliero, Universitaria Pisana is the lead sponsor of 56 studies on the registry; 10 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients underwent total hip replacement in elective surgery
Exclusion Criteria:
in this group of patients the peng block was performed with 15 ml of ropivacaine, whose dose was obtained on the weight
Drug: Ropivacaine
in this group of patients the peng block was performed with 20 ml of ropivacaine, whose dose was obtained on the weight
Drug: Ropivacaine
in this group of patients the peng block was performed with 30 ml of ropivacaine, whose dose was obtained on the weight
Drug: Ropivacaine
The local anesthetic was dosed on the patient's weight (50-59kg: 120mg, 60-61kg: 140mg, 70-79kg: 160mg, ≥80kg: 180mg)
NRS evaluation
Evaluate pain for every volume group in the first 24 hours post surgery using the Numeric Pain Scale (NRS) assigning a numeric value between zero (no pain) and ten (the worst pain ever felt). Absence of relevant pain is considered a NRS less than three. Success of the block was defined as NRS≤3.
Time frame: 24h post-op
NRS variation in time
consider variation of pain, assessed with numeric Pain scale, for each group, every six hours
Time frame: 24 h
presence of side effects
Monitoring the onset of side effects (nausea/vomiting/hypotension/dizziness/sensitive impareiment) in every group of patients in the first 24 hours every six hours
Time frame: 24 hours
analgesic requirements
requirement of analgesic to control the pain, assessed every six hours
Time frame: 24 hours
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in May 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Azienda Ospedaliero, Universitaria Pisana